18 May 2013
Keywords: immtech, pcp, drug, enters, ph, iii, trial
Article | 03 April 2006
USA-based Immtech Pharmaceuticals has initiated a domestic Phase III pivotal trial of its oral drug pafuramidine maleate in the treatment ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 April 2006
17 May 2013
© 2013 thepharmaletter.com